Significant Ownership of First Light Asset Management, LLC
- Signature and title
- /s/ Kurt T. Peterson - Kurt T. Peterson/Chief Compliance Officer
- Location
- Edina, MN
- Schedule 13D/G summary
- Recent SEC Schedule 13D/G filings for First Light Asset Management, LLC, focused on large-stake beneficial ownership disclosures and amendments.
Manager identity
2 facts
Large-stake snapshot
1 fact
Follow Filing Activity
Follow First Light Asset Management, LLC and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from First Light Asset Management, LLC
Significant Ownership of First Light Asset Management, LLC
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SIBN | SI-BONE, Inc. | Common Stock, $0.001 par value | 18% | $107,278,225 | +$38,975,022 | 8,120,986 | +57% | Mathew P. Arens | 30 Apr 2026 |
| HCAT | Health Catalyst, Inc. | Common Stock, $0.01 par value | 18% | $26,796,092 | -$909,928 | 13,465,373 | -3.3% | Mathew P. Arens | 12 Mar 2026 |
| MASS | 908 Devices Inc. | Common Stock, $0.001 par value | 17% | $33,397,591 | +$8,120,952 | 6,184,739 | +32% | Mathew P. Arens | 31 Dec 2025 |
| PHLT | Performant Healthcare, Inc. | Common Stock, $0.01 par value | 16% | $53,117,291 | 12,923,915 | Mathew P. Arens | 30 Jun 2025 | ||
| SLP | Simulations Plus, Inc. | Common Stock, $0.001 par value | 13% | $48,307,294 | 2,649,879 | First Light Asset Management, LLC | 31 Jan 2026 | ||
| NEO | Neogenomics, Inc. | Common Stock, $0.01 par value | 11% | $115,847,880 | +$35,417,243 | 14,093,416 | +44% | Mathew P. Arens | 30 Apr 2026 |
| TLSI | TriSalus Life Sciences, Inc. | Common Stock, $0.01 par value | 8.8% | $22,463,809 | 5,374,117 | First Light Asset Management, LLC | 31 Mar 2026 | ||
| NPCE | NeuroPace, Inc. | Common Stock, $0.01 par value | 8.7% | $38,863,812 | 2,955,423 | Mathew P. Arens | 31 Mar 2026 | ||
| KRMD | KORU Medical Systems, Inc. | Common Stock, $0.01 par value | 8.3% | $21,417,945 | -$5,550,194 | 3,831,475 | -21% | Mathew P. Arens | 31 Dec 2025 |
| PVLA | PALVELLA THERAPEUTICS, INC. | Common Stock, $0.01 par value | 7.5% | $89,137,745 | 887,031 | First Light Asset Management, LLC | 31 Dec 2025 | ||
| AXGN | Axogen, Inc. | Common Stock, $0.01 par value | 6.8% | $119,861,458 | -$76,951,680 | 3,617,913 | -39% | Mathew P. Arens | 30 Apr 2026 |
| ANAB | AnaptysBio Inc. | Common Stock, $0.01 par value | 3.1% | $26,474,603 | -$42,907,347 | 864,618 | -62% | Mathew P. Arens | 30 Sep 2025 |
| ORGO | Organogenesis Holdings Inc. | Common Stock, $0.01 par value | 3.1% | $16,371,915 | -$18,610,675 | 3,888,816 | -53% | Mathew P. Arens | 31 Dec 2025 |
| FNA | Paragon 28, Inc. | Common Stock, $0.01 par value | 1.7% | $18,718,661 | -$119,897,999 | 1,429,997 | -86% | Mathew P. Arens | 28 Feb 2025 |
| OPRX | OptimizeRx Corporation | Common Stock, $0.01 par value | 0% | $0 | 0 | First Light Asset Management, LLC | 31 Dec 2024 |
Schedules 13D/G Reported by First Light Asset Management, LLC:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.